Laekna Therapeutics is a biotech startup focused on revolutionizing cancer and liver disease treatment. Founded in 2016, the company is based in Shanghai, China and New Jersey, USA. Their strategy involves obtaining global licenses for promising drug candidates in the clinical stage of development. By targeting large unmet medical needs, Laekna aims to develop groundbreaking therapies that improve patient outcomes in oncology and liver diseases.